ABSTRACT
BACKGROUND: Mitral valve disease is often accompanied by atrial fibrillation, which may compromise the patient even after the valvular lesion has been repaired. METHODS: Three patients with rheumatic type mitral valve disease and chronic atrial fibrillation were treated by mitral valve replacement with cryopreserved mitral valve homograft and Maze III procedure, as a method to relieve both the valvular pathology and the rhythm disorder. The patients' clinical courses have been followed for up to 1 year after operation. RESULTS: All patients survived operation, and all have normal sinus rhythm. None are taking cardiac medications. CONCLUSIONS: Long-term treatment with warfarin should not be required, and other cardiac medicines may be eliminated following mitral valve replacement with homograft combined with Maze III procedure.
Subject(s)
Cardiac Surgical Procedures/methods , Mitral Valve Stenosis/surgery , Aged , Atrial Fibrillation/etiology , Atrial Fibrillation/surgery , Female , Humans , Male , Middle Aged , Mitral Valve , Mitral Valve Stenosis/complicationsABSTRACT
We report the unusual occurrence of severe intra-vascular haemolysis following mitral valve repair. Mild to moderate mitral regurgitation was detected after repair, but severe haemolysis was the only indication for re-operation. Following prosthetic valve replacement there was an immediate cessation of haemolysis. We postulate that a small regurgitant jet directed against the teflon pledgets used in the repair was the reason for the haemolysis.